°³¶ËÀ̳׿¡¼­ ÆÇ¸ÅµÈ "µ¶¼ºÇÐÀÇ ºÐÀÚ-»ýÈ­ÇÐÀû ¿ø¸®"     Á¤°¡ 38,000¿ø   Æò±ÕÇÒÀΰ¡
Ãß°¡ °Ë»ö Çϱâ
ÃÑ 2°³ÀÇ µµ¼­°¡ ÀÖ½À´Ï´Ù.
µµ¼­À̹ÌÁö µµ¼­¸í »óÅ °¡°Ý ÆǸÅÀÚ

µ¶¼ºÇÐÀÇ ºÐÀÚ-»ýÈ­ÇÐÀû ¿ø¸®
»õÃ¥ 
34,200¿ø

¹«·á¹è¼Û
Ã¥°¡¹æ
ÆǸŵµ¼­(328,774±Ç)

µ¶¼ºÇÐÀÇ ºÐÀÚ-»ýÈ­ÇÐÀû ¿ø¸®
»õÃ¥ 
34,200¿ø

¹«·á¹è¼Û
»õÃ¥Àü¹®Á¡
ÆǸŵµ¼­(360,129±Ç)
 

»ó¼¼Á¤º¸

[1] µ¶¼ºÇÐÀÇ ºÐÀÚ£­»ýÈ­ÇÐÀû ¿ø¸®¿Í Central dogma
1. µ¶¼ºÇÐÀÇ ºÐÀÚ£­»ýÈ­ÇÐÀû ¿ø¸®¿Í Central dogma
2. µ¶¼º¹ßÇöÀ» À§ÇÑ È­ÇаáÇÕ ¹× È­ÇÐÀû Ư¼º
3. À¯±âÈ­Çй°Áú°ú µ¶¼º¹°ÁúÀÇ °³³ä°ú ºÐ·ù
4. BiotransformationÀÇ °³³ä

[2] Á¦1»ó¹ÝÀÀ(Phase I reaction)£­Cytochrome P450£­ÀÇÁ¸¼º »ýüÀüȯ
1. Cytochrome P450ÀÇ ¹ß°ß°ú ºÐ·ù
2. Cytochrome P450ÀÇ ±¸Á¶(topology)¿Í ±âÁúƯÀ̼º
3. P450ÀÇ ºÐÆ÷ÇÏ´Â Á¶Á÷, ¼¼Æ÷ ±×¸®°í ¼¼Æ÷¼Ò±â°ü¿¡ À־ ƯÀ̼º(specificity)
4. Cytochrome P450ÀÇ Ã˸ŹÝÀÀ »çÀÌŬ(catalytic cycle)
5. P450¿¡ ÀÇÇÑ 4°¡Áö ÁÖ¿ä Ã˸ŹÝÀÀ
6. P450 À¯ÀüÀÚ ¹× À¯µµ±âÀü(induction mechanism)
7. P450ÀÇ È°¼ºÀúÇرâÀü
8. Toxicants£­drug metabolism enzyme families: CYP1, 2, 3
9. Extrahepatic tissues¿¡¼­ÀÇ P450 ¹ßÇö£­CYP1, CYP2¿Í CYP3 °è¿­
10. P450ÀÇ À¯µµ°³½Ã¿Í È¿¼ÒºÐÇØ

[3] Á¦1»ó¹ÝÀÀ(Phase 1 reaction)£­Cytochrome P450 ¿ÜÀÇ ÁÖ¿ä È¿¼Ò¿¡ ÀÇÇÑ »ýüÀüȯ
1. Flavin mono£­oxygenase
2. Epoxide hydrolase
3. Monoamine oxidase
4. Alcohol dehydrogenase¿Í acetaldehyde dehydrogenase µîÀ» ºñ·ÔÇÑ ¿¡Åº¿Ã ºÐÇØ È¿¼Ò
5. Quinone reductase
6. Xanthine oxidoreductase

[4] Á¦2»ó¹ÝÀÀ(Phase 2 reaction)¿¡ ÀÇÇÑ »ýüÀüȯ
1. Glucuronic acid conjugation
2. Sulfate conjugation
3. Acetylation conjugation
4. Methylation
5. Amino acid conjugation
6. GSHÆ÷ÇÕ¹ÝÀÀ
7. Á¦1»ó¹ÝÀÀ ¹× Á¦2»ó¹ÝÀÀÀÇ gene£­coordinate regulation

[5] »ýüȰ¼ºÈ­(Bioactivation)£­Reactive intermediates
1. Reactive intermediates£­Electrophilic metabolites
2. Carbon£­centered radical°ú Redox£­active species

[6] µ¶¹°µ¶·ÂÇÐ(Toxicodynamics)£­Reactive intermediates¿Í DNA, ÁöÁú, ´Ü¹éÁú µî°úÀÇ »óÈ£ÀÛ¿ë
1. È°¼ºÁß°£´ë»çü¿¡ ÀÇÇÑ DNA ¼Õ»ó
2. È°¼ºÁß°£´ë»çü¿¡ ÀÇÇÑ ´Ü¹éÁú ¹× ÁöÁú ¼Õ»ó

[7] È­ÇÐÀû ¹ß¾ÏÈ­(Chemical carcinogenesis)
1. ¹ß¾ÏÀÇ multistage theory
2. ¹ß¾ÏÈ­¿¡ ´ëÇÑ ½ÉÃþÀû ÀÌÇØ

- Âü°í¹®Çå
- »öÀÎ

ÀÌ Ã¥ "µ¶¼ºÇÐÀÇ ºÐÀÚ£­»ýÈ­ÇÐÀû ¿ø¸®"´Â ü³»¿¡¼­ À¯±â¹°ÁúÀÇ µ¶¼ºÀ¯¹ß¿¡ À־ ±âº»¿ø¸®¿¡ ´ëÇÑ ÀÌÇظ¦ À§ÇÏ¿© ºÐÀÚ»ý¹°ÇÐ ¹× »ýÈ­ÇÐ Ãø¸é¿¡¼­ Á¢±ÙÇÏ°í ÀÖ´Ù. IARC(±¹Á¦¾Ï¿¬±¸¼Ò)ÀÇ ÀÎü¹ß¾Ï¹°Áú ºÐ·ù¿¡ µû¸£¸é 61Á¾ÀÇ ÀÎü¹ß¾Ï¹°Áú Áß 90% ÀÌ»óÀÌ À¯±â¹°ÁúÀ̶ó°í ÇÑ´Ù. ÀÌ·Î º¸¾Æ À¯±â¹°ÁúÀÌ ¹«±â¹°Áúº¸´Ù µ¶¼ºÇÐÀû Ãø¸é¿¡¼­ ´õ ½É°¢ÇÑ °Ç°­À§Çظ¦ Áشٰí ÇÒ ¼ö ÀÖÀ» °ÍÀÌ´Ù. ¶ÇÇÑ »ê¾÷Àû, ȯ°æÀû ¶Ç´Â °³ÀÎ ½À°üÀû °æ·Î¸¦ ÅëÇØ ³ëÃâµÇ´Â È­Çй°Áú Áß À¯±â¹°ÁúÀÌ º¸´Ù ´õ Å« ºñÁßÀ» Â÷ÁöÇÏ´Â °Íµµ »ç½ÇÀÌ´Ù.

ÀúÀÚ´Â ºÐÀÚ»ý¹°ÇÐÀÇ ÇÙ½ÉÀ» °£´ÜÈ÷ ¼³¸íÇÏ´Â µ¥ À־ 'Central dogma(Áß½ÉÀÌ·Ð)'°¡ °¡Àå ¸¹ÀÌ ÀÌ¿ëµÇ°í ÀÖ°í À¯±â¹°Áú¿¡ ´ëÇÑ µ¶¼ºÇÐÀÇ ºÐÀÚ£­»ýÈ­ÇÐÀû ¿ø¸®´Â 'Central dogma'¿¡ ´ëÇÑ ÀÌÇØÀ̸ç ÀÌ´Â ´ëºÎºÐ À¯±âÈ­Çй°ÁúÀÇ °øÅëÀûÀÎ µ¶¼º±âÀüÀ¸·Î °í·ÁÇÒ ¼ö ÀÖ´Ù°í ¸»ÇÑ´Ù. ¿ªÀ¸·Î µ¶¼ºÇÐÀÇ ºÐÀÚ£­»ýÈ­ÇÐÀû ¿ø¸®¿¡ ´ëÇÑ Á¢±ÙÀº µ¶¼º¹°ÁúÀÇ Ã¼³» µ¿ÅÂ¿Í °ü·ÃµÈ È¿¼ÒÀÇ È°¼º°ú ÀúÇØ¿¡ ´ëÇÑ ÀÌÇظ¦ À§ÇÑ °ÍÀÌ¸ç ¶ÇÇÑ À̸¦ ÅëÇØ »õ·Î¿î ¾à¹° ¹× ±â´É¼º½ÄÇ°ÀÇ °³¹ß¿¡ ÀÀ¿ëµÇ±æ ¹Ù¶ó´Â ¸¶À½À¸·Î Àú¼úÇÏ¿´À½À» ¹àÈ÷°í ÀÖ´Ù.

ÀÌ Ã¥ÀÇ 1Àå¿¡¼­´Â Central dogmaÀÇ ÀÌÇØ¿Í µ¶¼º¹ßÇöÀ» È­ÇÐÀû Ư¼º, µ¶¼º¹°ÁúÀÇ °³³ä°ú ºÐ·ù¿¡ ´ëÇØ ¼³¸íÇÑ´Ù. 2Àå¿¡¼­´Â Á¦1»ó¹ÝÀÀ(phase 1)£­Cytochrome P450£­ÀÇÁ¸¼º »ýüÀüȯ¿¡ ´ëÇØ ¸»ÇÏ°í 3ÀåÀº Á¦1»ó¹ÝÀÀ(Phase 1 reaction)£­Cytochrome P450 ¿ÜÀÇ ÁÖ¿ä È¿¼Ò¿¡ ÀÇÇÑ »ýüÀüȯ, 4Àå¿¡¼­´Â Á¦2»ó¹ÝÀÀ(Phase 2 reaction)¿¡ ÀÇÇÑ »ýüÀüȯ¿¡ ´ëÇØ ¼³¸íÇÑ´Ù. 5ÀåÀÇ ÁÖÁ¦´Â »ýüȰ¼ºÈ­(Bioactivation)ÀÌ°í 6Àå¿¡¼­´Â µ¶¹°µ¶·ÂÇÐ(Toxicodynamics)£­Reactive intermediates¿Í DNA, ÁöÁú, ´Ü¹éÁú µî°úÀÇ »óÈ£ÀÛ¿ë¿¡ ´ëÇØ »ó¼¼È÷ ¹àÈù´Ù. 7ÀåÀÇ ÁÖÁ¦´Â È­ÇÐÀû¹ß¾Ï(Chemical carcinogenesis)À¸·Î ¾Ï¼¼Æ÷¿¡ ´ëÇÑ È­ÇÐÀû ¼³¸íÀÌ´Ù.
 

¼­Æòº¸±â

´ÜÇົ BEST µµ¼­

³ªÀǼîÇÎ

  • Ä«µå³»¿ªÁ¶È¸
  • ¸¸Á·µµº¸±â
  • ÆǸÅÀÚº¸±â

ÃÖ±Ùº»»óÇ°

Àå¹Ù±¸´Ï

TOP